Discover Echo
The company offers microscopes and software for live cell imaging and analysis.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
$110m Valuation: $110m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Discover Echo is a pioneering company in the field of microscopy, offering innovative hybrid microscopes that seamlessly convert between upright and inverted configurations. This unique capability addresses a significant need in research labs, where 71% currently own both types of microscopes. By integrating ultra high-resolution touch displays and intuitive software, Discover Echo enhances the user experience and improves workflow efficiency. The company's flagship product, Cellcyte Gen 2, allows real-time imaging of live cells within incubators, providing reliable and reproducible results. Discover Echo serves research institutions, pharmaceutical companies, and biotech firms, operating in the global life sciences market. The business model focuses on selling advanced microscopy equipment and software solutions, generating revenue through direct sales and service contracts. Discover Echo aims to reduce organ shortages and accelerate drug development by merging biology with cutting-edge technology, fundamentally transforming the healthcare industry.
Keywords: hybrid microscopes, life sciences, drug development, live cell imaging, ultra hi-res displays, intuitive software, research labs, biotechnology, healthcare innovation, microscopy equipment.